Products and Services - MACS Cell Culture and Stimulation - Antigen delivery

Antigen delivery

  • Elegant delivery of Ova or CMV pp65 into cells via antigen uptake receptors
  • Use any antibody to target an antigen uptake receptor of your choice
  • Standardized control to test your own delivery system
  • Comprehensive experimental protocol included in the box
Antigen delivery to antigen-presenting cells (APCs) via specific receptors has been recognized as an effective method of inducing specific T cell responses. Ovalbumin (Ova) is widely used as a model antigen for the characterization of antigen uptake, processing and presentation. On the other hand, Cytomegalovirus (CMV) is one of the most-studied viruses in humans and CMV-derived pp65 is important both as a model antigen and diagnostic marker as well as a potential therapeutic target. Choose between a full-length protein antigen (Ova) and an overlapping peptide pool spanning the entire sequence (CMV pp65).
View "10" | "50" | "100" products/page
Showing 1-3 of 3
Product Order no. Price

hCMV-pp65 Antigen Delivery Reagent

Capacity: for 20 tests (1)

Capacity

(1)One test corresponds to labeling of up to 106 cells in a total volume of 100 µL.
 
130-095-406 $480.00

Ova Antigen Delivery Module Set

Components:
  • CD11c MicroBeads UltraPure, mouse (130-108-338)
  • CD205 (DEC205)-Biotin, mouse (130-101-854)
  • Ova Antigen Delivery Reagent (130-094-663)
  • Anti-MHC Class II-PE, mouse (130-102-186)
 
130-094-831 $825.00

Ova Antigen Delivery Reagent

Capacity: for 20 tests (1)

Capacity

(1)One test corresponds to targeting of up to 106 cells.
 
130-094-663 $270.00
View "10" | "50" | "100" products/page
Showing 1-3 of 3

Customer login

Go

Forgot password?
Register for account

0 Shopping cart

Contact

Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
macs@miltenyibiotec.com
Contact overview

Product finder

Antibody panel builder

Toolbox

Loading...

Get rewarded for the reagents you love

Get rewarded for reagents

Change country

Please select your country to continue